TL;DR
This study reveals a novel, non-canonical role for the epigenetic regulator EED in heart maturation. Contrary to established models, EED's repressive function in adult cardiomyocytes is independent of its canonical role in H3K27me3 marking. Instead, EED interacts with and enhances the activity of histone deacetylases (HDACs), leading to the suppression of aberrant gene expression and preventing heart failure.
What Problem Does This Paper Address?
The Polycomb Repressive Complex 2 (PRC2) is a well-known epigenetic regulator, primarily studied for its role in gene silencing through the trimethylation of histone H3 lysine 27 (H3K27me3). This mechanism is crucial in rapidly dividing cells, where gene expression patterns are frequently reset. However, the precise mechanistic requirement of H3K27me3 for gene silencing, especially in post-mitotic cells like adult cardiomyocytes, remained unclear. Adult cardiomyocytes divide infrequently, meaning H3K27me3 is not constantly rewritten. This study investigates EED, a core component of PRC2, in this specific context to understand its function in heart maturation and whether its role extends beyond canonical H3K27me3 deposition.
Methods
The researchers employed a multi-pronged approach:
- Genetic Manipulation: They generated conditional knockout (CKO) mice where EED was specifically inactivated in cardiomyocytes (Eed<sup>CKO</sup>).
- Phenotypic Analysis: Echocardiography was used to assess heart function (fractional shortening), and histological analysis was performed to evaluate cardiac morphology and fibrosis.
- Molecular Techniques:
- Western Blotting: To confirm EED protein depletion and assess global histone acetylation levels (H3K27ac, H3K9ac, H4ac).
- RNA-sequencing (RNA-seq): To profile gene expression changes in Eed<sup>CKO</sup> cardiomyocytes compared to wild-type.
- Chromatin Immunoprecipitation followed by sequencing (ChIP-seq): To map the genome-wide distribution of H3K27me3, H3K27ac, EED, and HDAC2.
- Co-immunoprecipitation (Co-IP): To investigate physical interactions between EED and various HDACs.
- In vitro HDAC activity assay: To directly measure the effect of EED on HDAC2 enzymatic activity.
- Adeno-associated virus (AAV) mediated gene delivery: Used for temporal re-expression of EED and overexpression of HDAC1/2 in Eed<sup>CKO</sup> mice.
- HDAC inhibition: Using suberanilohydroxamic acid (SAHA) to assess the role of HDAC activity in EED rescue.
Datasets
The study generated and analyzed several key datasets:
- RNA-seq data: From purified adult cardiomyocytes of wild-type and Eed<sup>CKO</sup> mice.
- ChIP-seq data: For H3K27me3, H3K27ac, EED, and HDAC2 in isolated cardiomyocytes from wild-type and Eed<sup>CKO</sup> mice.
- Gene Ontology (GO) enrichment analysis: Performed on differentially expressed genes.
The high-throughput data are publicly available through the Cardiovascular Development Consortium Server and deposited in GEO (accession number GSE73771).
Key Insights and Ideas
- EED's non-canonical role in adult heart: The most striking finding is that EED's critical function in maintaining heart health in adult cardiomyocytes is not primarily mediated by its canonical role in H3K27me3 deposition. This challenges the long-held view of PRC2's function.
- EED as a co-activator of HDACs: EED physically interacts with and significantly enhances the deacetylase activity of HDACs, particularly HDAC2. This suggests EED acts as a positive regulator of HDAC function.
- H3K27ac as a key marker: Gene upregulation in EED-deficient hearts was strongly correlated with an increase in H3K27ac, an active histone mark, rather than a decrease in H3K27me3. This points to a shift in the epigenetic landscape towards activation.
- Epigenetic rewiring for therapeutic potential: The successful rescue of heart function and gene expression by re-expressing EED or overexpressing HDAC1/2 highlights the potential for epigenetic interventions to reverse organ dysfunction caused by aberrant epigenetic regulation.
Key Results
- Neonatal EED inactivation leads to lethal dilated cardiomyopathy: Eed<sup>CKO</sup> mice exhibited severe heart dysfunction, cardiac dilatation, and hypertrophy, with most dying within three months.
- Gene upregulation without H3K27me3 loss: In Eed<sup>CKO</sup> cardiomyocytes, genes associated with slow-twitch myofibers and heart failure were significantly upregulated, but this derepression was not accompanied by a global loss of H3K27me3.
- Increased H3K27ac in EedCKO hearts: Concurrently with gene upregulation, there was a marked increase in H3K27ac levels at the promoters of upregulated genes and globally.
- EED interacts with and enhances HDAC2 activity: Co-immunoprecipitation confirmed EED's interaction with HDACs, and in vitro assays showed EED could increase HDAC2's deacetylase activity by up to threefold.
- HDAC1/2 overexpression rescues EedCKO phenotype: Delivering HDAC1/2 via AAV vectors to Eed<sup>CKO</sup> mice normalized heart function, reduced expression of aberrant genes, and restored H3K27ac levels at target loci.
- HDAC inhibition blocks EED rescue: Treatment with a broad-spectrum HDAC inhibitor (SAHA) impaired the rescue of Eed<sup>CKO</sup> hearts by AAV-mediated EED re-expression, underscoring the critical role of HDAC activity.
Limitations and Future Work
- H3K27me3 persistence: The study notes that while EED inactivation reduced H3K27me3 in some regions, the majority of upregulated genes did not show a loss of this mark. This suggests that in adult cardiomyocytes, H3K27me3 might be more stable, and EED's role might involve maintaining existing marks rather than solely writing new ones.
- HDAC substrates: While the study strongly implicates H3K27ac, the authors acknowledge that HDACs have multiple substrates, and effects on other targets cannot be entirely excluded.
- Therapeutic translation: The successful rescue in mouse models is promising, but translating these findings to human therapies would require further investigation into the precise mechanisms and potential off-target effects.
- Complex interplay of epigenetic regulators: The paper highlights that multiple redundant repressive pathways operate in normal heart development, and their disruption in Eed<sup>CKO</sup> hearts might leave the system vulnerable to further perturbations like HDAC inhibition. Future work could explore how these redundancies are overcome and how EED's interaction with HDACs integrates with other epigenetic pathways.
Summary updated